$INM

$1.59 +$0.00 (0.0%) Close

$INM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$INM Management Team

Mr. Andrew Hull

Independent Chairman of the Board

Age 62

Compensation $65.50K USD

Sex Male

Mr. Eric Adams

President

Chief Executive Officer

Director

Age 62

Compensation $397.0K USD

Sex Male

Ms. N. Netta Jagpal

Chief Financial Officer

Age 52

Compensation $303.7K USD

Sex Female

Dr. Eric Hsu

Senior Vice President - Preclinical Research and Development

Age 55

Compensation $323.6K USD

Sex Male

Mr. Michael Woudenberg

Chief Operating Officer

Age 56

Compensation $347.1K USD

Sex Male

Mr. Colin Clancy

Vice President

Investor Relations and Corporate Communications

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Andrew Hull Independent Chairman of the Board	62	$65.50K USD	Male
Mr. Eric Adams President Chief Executive Officer Director	62	$397.0K USD	Male
Ms. N. Netta Jagpal Chief Financial Officer	52	$303.7K USD	Female
Dr. Eric Hsu Senior Vice President - Preclinical Research and Development	55	$323.6K USD	Male
Mr. Michael Woudenberg Chief Operating Officer	56	$347.1K USD	Male
Mr. Colin Clancy Vice President Investor Relations and Corporate Communications	-	-	Male

Board of Directors

From the proxy statement filed Nov 3, 2025

Directors

serving now

Independent

4 of 5

stated in the proxy; 1 not stated

Average tenure

4.0 years

from year joined

CEO also chairs the board

Andrew Hull

Director	Age	On board	Independent	Committees	Other public boards	Pay
Bryan Baldasare Leaving at the meeting	Not stated	2022 3 years	Not stated	None stated	None stated	Not stated
Andrew Hull Board chair	62	2016 9 years	Independent	None stated	None stated	Not stated
Nicole Lemerond	50	2022 3 years	Independent	Compensation Committee · Chair	GeoVax Labs, MediciNova	Not stated
Neil Klompas	53	2025 0 years	Independent	None stated	NervGen Pharma	Not stated
John Bathery	56	2025 0 years	Independent	None stated	None stated	Not stated
Eric A. Adams CEO	62	2016 9 years	Not independent	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Nov 3, 2025

Norton Rose Fulbright Canada LLP

Ms. Grove is a partner of Norton Rose Fulbright Canada LLP; Ms. Grove was a director of the Company until February 10, 2025

$316,977

July 1, 2024 to February 10, 2025

Legal services rendered by NRF (NRFC and Norton Rose Fulbright US LLP) to the Company, July 1, 2024 to February 10, 2025

With the Company Open in proxy

Norton Rose Fulbright Canada LLP

Ms. Grove is a partner of Norton Rose Fulbright Canada LLP; Ms. Grove was a director of the Company until February 10, 2025

$226,793

twelve months ended June 30, 2024

Legal services rendered by NRF to the Company in the twelve months ended June 30, 2024

With the Company Open in proxy

Comments

Company Executives

$INM Management Team

Mr. Andrew Hull

Mr. Eric Adams

Ms. N. Netta Jagpal

Dr. Eric Hsu

Mr. Michael Woudenberg

Mr. Colin Clancy

Board of Directors

Related-party transactions